Multicenter Phase II Trial of Chemoradiation With Oxaliplatin for Rectal Cancer

2006228 citationsJournal Article

Authors

Claus Rödel · Wittenberg University

Torsten Liersch · Wittenberg University

Robert Michael Hermann · Wittenberg University

Dirk Arnold · Wittenberg University

Thomas S. Reese · Wittenberg University

Matthias Hipp · Wittenberg University

Alois Fürst ·

Abstract

Preoperative XELOX-RT plus four cycles of adjuvant XELOX is an active and feasible treatment. This regimen is proposed for phase III evaluation comparing standard fluorouracil-based treatment with XELOX- based multimodality treatment.

Topics & Keywords

Colorectal Cancer Surgical Treatments Colorectal Cancer Treatments and Studies Gastric Cancer Management and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 25, Issue 1, pp. 110-117

DOI: 10.1200/jco.2006.08.3675

Field-Weighted Citation Impact: 10.96